#TSP TruSpine Technologies PLC – Result of 2025 AGM December 10, 2025 – Posted in: TruSpine Plc (TSP)

TSP Advanced Technologies plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that at its 2025 AGM held earlier today all resolutions were duly passed. Details of the votes received will be available shortly on the Company’s website. The Directors of the Company are responsible for the release of this announcement. -END- TSP Investor Hub https://truspinetech.com/aqse-rule-4-14 TSP Advanced Technologies plc Tel: +44 (0)20 7118 0852 Geoff Miller, Non-executive Chairman Cairn…

#TSP TruSpine Technologies PLC – Delay to the publication of accounts & Suspension October 1, 2025 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces a delay to the completion and publication of its audited accounts for the year to 29 March 2025. Accordingly, pursuant to Rule 5.1 of the AQSE Growth Market Access Rulebook, a temporary suspension of trading in the Company’s shares will take effect from 08:00 today (1 October 2025). The Company anticipates that it will be in a position to publish…

#TSP TruSpine Technologies PLC – Convertible Loan Note Extension & RPT July 24, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, that further to the announcement on 28 March 2024, the Company has extended the maturity date of the convertible loan note (“CLN”) to 30 June 2025. All other terms of the CLN remain unchanged. Related Party Transaction The extension of maturity date of the CLN (the “Transaction”) is a related party transaction for the purposes of Rule 4.6 of the AQSE…

#VELA investee co. #KING Igraine PLC – Fixit Medical Ltd Receipt of Grant from Innovate UK July 3, 2024 – Posted in: Vela Technologies Plc (VELA)

The Board of Igraine (AQSE: KING), an investing company focused on breakthrough innovative technologies and discoveries in the healthcare and life sciences sectors, wishes to notify its shareholders of an update on its investee company, Fixit Medical Ltd (“Fixit”) in which the Company own a 20% interest. Fixit Medical Ltd Award of £270,000 Grant: We are delighted to announce that Fixit Medical Ltd has been awarded a £270,000 ‘UK Smart Grant’ by Innovate UK for…

#TSP Truspine Technologies PLC – Notice of 2023 AGM May 10, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that notice of the Company’s 2023 annual general meeting (“2023 AGM”) will be sent to shareholders shortly. The 2023 AGM will be held at the offices of Hill Dickinson LLP at The Broadgate Tower, 20 Primrose Street, London, EC2A 2EW on 7 June 2024 at 11:30 am. A copy of the notice of the 2023 AGM, along with…

#TSP Truspine Technologies PLC – Convertible Loan, Loan Update, AGM Update and RPT February 14, 2024 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, announces that it has entered into a £50,000 convertible loan note agreement with Martin Armstrong (the “CLN Agreement”), the former Non-Executive Chairman of the Company. The Company also provides an update on the loan agreement announced on 5 January 2024 and on its 2022 annual general meeting (“2022 AGM”) which is due to be convened. CLN Agreement Pursuant to the…

#TSP TruSpine Technologies PLC – IP Registration October 25, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces that it has, with the help of the Company’s newly appointed IP lawyers, published the original assignment of the Intellectual Property Rights to the Company as per the Original IP Agreement and Addendum. The patents acquired as part of the Intellectual Property Rights can be viewed at the following link: https://assignment.uspto.gov/patent/index.html#/patent/search/resultAssignee?assigneeName=TRUSPINE%20TECHNOLOGIES%20LIMITED Capitalised terms…

#TSP TruSpine PLC – Further re: FDA Update October 12, 2023 – Posted in: TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems announces that, further to the announcement on 3 October 2023, the Company has submitted additional documentation and provided further clarification in regard to the questions raised by the U.S. Food and Drug Administration (“FDA”) relating to the Company’s FDA 510(k) application. TruSpine CEO Laurence Strauss commented: “We are pleased the US FDA have responded…

#TSP TruSpine Technologies PLC – Final Results September 29, 2023 – Posted in: Blog, TruSpine Plc (TSP)

TruSpine Technologies plc, (AQSE: TSP) the medical device company focused on the development of its pioneering “screwless,” spinal (vertebral) stabilisation systems, reports its full year results for the year ended 29 March 2023. The Company continues to be in a pre-revenue development phase and remains loss making at this stage of its development. The loss before taxation for the year was £853k (2022: £941k) after administrative expenses of £846k (2022: £938k). The R&D tax…

#VELA Vela Technologies PLC investee Co. #TSP TruSpine PLC – Further re Bridge Loan Facility & Letter of Intent February 20, 2023 – Posted in: Vela Technologies Plc (VELA)

TruSpine Technologies Plc, the medical device company focused on the spinal (vertebral) stabilisation market, provides an update in relation to the announcement released on 8 February 2023 concerning the expected receipt of funding from the Bridge Loan facility and the subscription for Tranche 1 of the staged equity funding under the LOI entered into with the Investment Group. Funding from the Bridge Loan facility has not yet been received by the Company, however the…